|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-3-3
|
|
pubmed:abstractText |
Although HAART has led to a reduction in overall mortality among HIV-infected individuals, its impact on death from specific causes is unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
741-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16514305-AIDS-Related Opportunistic Infections,
pubmed-meshheading:16514305-Adult,
pubmed-meshheading:16514305-Anti-HIV Agents,
pubmed-meshheading:16514305-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16514305-CD4 Lymphocyte Count,
pubmed-meshheading:16514305-Cause of Death,
pubmed-meshheading:16514305-Cohort Studies,
pubmed-meshheading:16514305-Disease Progression,
pubmed-meshheading:16514305-Female,
pubmed-meshheading:16514305-Follow-Up Studies,
pubmed-meshheading:16514305-HIV Infections,
pubmed-meshheading:16514305-HIV Seropositivity,
pubmed-meshheading:16514305-HIV-1,
pubmed-meshheading:16514305-Hepatitis,
pubmed-meshheading:16514305-Humans,
pubmed-meshheading:16514305-Incidence,
pubmed-meshheading:16514305-Lymphoma, AIDS-Related,
pubmed-meshheading:16514305-Male,
pubmed-meshheading:16514305-Multivariate Analysis,
pubmed-meshheading:16514305-RNA, Viral,
pubmed-meshheading:16514305-Risk,
pubmed-meshheading:16514305-Substance Abuse, Intravenous
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
|
|
pubmed:affiliation |
Municipal Health Service, Amsterdam, The Netherlands. csmit@ggd.amsterdam.nl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
